Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Medical treatment guidelines for diabetes

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

10 Jul 2014

Gerresheimer substantially increases earnings in second quarter of financial year 2014

Gerresheimer AG substantially increased earnings in the second quarter of financial year 2014."High-quality packaging for drugs and products enabling safe and easy self-medication continues to be increasingly in demand worldwide.

10 Jul 2014

Acetone in breath is suitable marker of fat-burning during physical activity

Physicists at Radboud University Nijmegen have shown for the first time that the concentration of acetone in breath is a suitable marker of fat-burning during physical activity.

9 Jul 2014

Trauma device and reconstructive joint implant market in Latin America expected to reach $1.75 billion by 2022

Decision Resources Group finds that the market for trauma devices and reconstructive joint implants in Argentina, Brazil, Colombia and Mexico will be driven by favorable demographics, high numbers of motor vehicle accidents and improving access to health care, which will allow more patients to undergo these procedures.

9 Jul 2014

Insulin pumps better than injections for glycaemic control in Type 2 diabetes

Patients with Type 2 diabetes achieve better glycaemic control with insulin pumps than multiple insulin injections, show the findings of the OpT2mise randomised trial.

4 Jul 2014

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

It has been known for its flavorful addition to soups and as a delicacy for dogs but bone marrow fat may also have untapped health benefits, new research finds.

4 Jul 2014

Transcription factor IRF4 plays key role in brown fat's thermogenic process

The body contains two types of fat cells, easily distinguished by color: White and brown. While white fat serves to store excess calories until they're needed by the body, brown adipocytes actually burn fat by turning it into heat.

4 Jul 2014

Promising new drug for metabolic syndrome

University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome, a finding that has a U of U spinoff company developing a drug to potentially treat the condition.

4 Jul 2014

Diabetes easier to control with insulin pump than self-injections?

Insulin pump therapy may be an effective alternative for people who cannot control their diabetes effectively using daily self-injections, show study findings.

3 Jul 2014

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

Building upon their earlier research on the biology of fat metabolism, Joslin scientists discovered that microRNAs -small RNA molecules that play important roles in regulation in many types of tissue - play a major role in the distribution and determination of fat cells and whole body metabolism.

3 Jul 2014

A*STAR scientists pioneered a molecular connection between obesity and diabetes

Scientists from the Institute of Molecular and Cell Biology, a research institute under the Agency for Science, Technology and Research, have discovered that obese individuals lack a protein that is essential for regulating blood glucose levels, causing them to face higher risks of developing diabetes.

1 Jul 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.

30 Jun 2014

Research provides new insight into effects of adding fructose to Western diet high in fat

A high-fructose, high-fat diet can cause harmful effects to the livers of adult rats, according to new research published in Experimental Physiology, providing new insight into the effects of adding fructose to a Western diet high in fat.

28 Jun 2014

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.

28 Jun 2014

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease.

25 Jun 2014

Fatty acids in nuts help reduce risk of CHD in people with type 2 diabetes

Findings from a new study published in Nutrition, Metabolism & Cardiovascular Diseases show that the fatty acids in nuts have the potential to help reduce the risk of coronary heart disease (CHD) in people with type 2 diabetes.

25 Jun 2014

Discovery provides scientists with better understanding of limiting uncontrolled cell growth

Biologists at UC San Diego have found the "missing link" in the chemical system that enables animal cells to produce ribosomes-the thousands of protein "factories" contained within each cell that manufacture all of the proteins needed to build tissue and sustain life.

24 Jun 2014

Pilot study to evaluate advanced artificial pancreas technology under real-world situations

For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with type 1 diabetes (T1D) to go about their daily lives and sleep through the night with less worry about life-threatening blood-sugar highs and lows.

24 Jun 2014

Growth hormone deficiency may protect people from developing Type 2 diabetes, cancer

People who lack growth hormone (GH) receptors also appear to have marked insulin sensitivity that prevents them from developing diabetes and lowers their risk for cancer, despite their increased percentage of body fat, new research finds.

24 Jun 2014

Insulin News and Research

Further Reading

Medical treatment guidelines for diabetes

Gerresheimer substantially increases earnings in second quarter of financial year 2014

Acetone in breath is suitable marker of fat-burning during physical activity

Trauma device and reconstructive joint implant market in Latin America expected to reach $1.75 billion by 2022

Insulin pumps better than injections for glycaemic control in Type 2 diabetes

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

Transcription factor IRF4 plays key role in brown fat's thermogenic process

Promising new drug for metabolic syndrome

Diabetes easier to control with insulin pump than self-injections?

Study reveals mechanism underlying abnormal fat accumulation in HIV patients

A*STAR scientists pioneered a molecular connection between obesity and diabetes

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

Research provides new insight into effects of adding fructose to Western diet high in fat

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Fatty acids in nuts help reduce risk of CHD in people with type 2 diabetes

Discovery provides scientists with better understanding of limiting uncontrolled cell growth

Pilot study to evaluate advanced artificial pancreas technology under real-world situations

Growth hormone deficiency may protect people from developing Type 2 diabetes, cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News